Drugs / Attenuated Mumps vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04591405 | Oct 2020 → Jul 2024 | mumps infectious disease | Institute of Medical Biology, Chinese Academy of Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Attenuated Mumps vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04591405 ↗ |
| Modality | Vaccine | “Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17)” NCT04591405 ↗ |